M08.95
Juvenile arthritis, unspecified, hip
Clinical Classification Guidelines
Medical Intelligence & Overview
Juvenile arthritis, also known as juvenile idiopathic arthritis (JIA), is a chronic inflammatory condition affecting children and adolescents. When this condition involves the hip joint, it can cause pain, swelling, and limited movement, impacting a young person's daily activities. The ICD-10 code M08.95 specifically identifies juvenile arthritis affecting the hip without further specification of the subtype. Early recognition and management are vital to prevent joint damage and improve quality of life for affected children.
Causes & Symptoms
Clinical Causes: Genetic factors: A family history of autoimmune diseases may increase risk. Immune system dysfunction: An abnormal immune response mistakenly attacking joint tissues. Environmental triggers: Infections or other environmental factors possibly contributing to disease onset. Age factors: Typically begins before the age of 16, with onset usually between 1 and 6 years. Subtype variability: The exact cause can vary depending on the specific subtype of juvenile arthritis.
Key Symptoms: Joint swelling, tenderness, and warmth, especially around the hip. Persistent pain that may worsen with activity or movement. Limping or favoring the affected leg due to discomfort or limited mobility. Reduced range of motion in the hip joint, affecting walking or other movements. Possible systemic symptoms like fever, rash, or fatigue in certain subtypes. Muscle weakness around the hip due to disuse or inflammation.
Diagnostic & Treatment
Diagnosis Path: Diagnosis of juvenile arthritis of the hip involves a combination of medical history, physical examination, and various tests. Healthcare providers assess symptoms and look for signs of inflammation or joint damage. Laboratory tests such as blood work can identify inflammation markers or rule out infections. Imaging studies, including X-rays or MRI, help evaluate the extent of joint inflammation or damage. Often, diagnosis is made after other causes of joint pain are excluded, and the criteria for juvenile arthritis are met for a period of at least six weeks.
Treatment Protocols: While there is no cure for juvenile arthritis, multiple treatment strategies aim to control inflammation, relieve symptoms, and prevent joint damage. These may include: - Nonsteroidal anti-inflammatory drugs (NSAIDs): To reduce pain and inflammation. - Disease-modifying antirheumatic drugs (DMARDs): Including methotrexate, to slow disease progression. - Biological agents: Such as TNF inhibitors for more severe cases. - Physical therapy: To maintain joint flexibility and muscle strength. - Range-of-motion exercises: To prevent stiffness in the hip. - Regular monitoring: To assess disease activity and adjust treatment as necessary. In some cases, surgical options like joint aspiration or even joint replacement might be considered if joint damage becomes significant.
Clinical Advice & FAQs
Billing Guidance
Is M08.95 a billable ICD-10 code?
Yes, M08.95 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report M08.95?
Clinical documentation must specify the nature of Juvenile arthritis, unspecified, hip and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
